SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001144204-14-000833
Filing Date
2014-01-07
Accepted
2014-01-06 18:50:09
Documents
9

Document Format Files

Seq Description Document Type Size
1 FORM F-1/A v364061_f-1a.htm F-1/A 2056609
2 GRAPHIC theader.jpg GRAPHIC 6238
3 EXHIBIT 23.1 v364061_ex23-1.htm EX-23.1 2646
  Complete submission text file 0001144204-14-000833.txt   11361619

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT clsxy-20130930.xml EX-101.INS 1823728
5 XBRL TAXONOMY EXTENSION SCHEMA clsxy-20130930.xsd EX-101.SCH 72150
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clsxy-20130930_cal.xml EX-101.CAL 26100
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clsxy-20130930_def.xml EX-101.DEF 326200
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE clsxy-20130930_lab.xml EX-101.LAB 384990
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clsxy-20130930_pre.xml EX-101.PRE 388686
Mailing Address C/O MARK COHEN, CHAIRMAN, PEARL COHEN 1500 BROADWAY, 12TH FLOOR NEW YORK NY 10036
Business Address 53 DAVIES STREET LONDON X0 W1K 5JH 646-878-0804
Celsus Therapeutics Plc. (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: F-1/A | Act: 33 | File No.: 333-192783 | Film No.: 14511530
SIC: 2834 Pharmaceutical Preparations